erythrosine has been researched along with saquinavir in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drewe, J; Fricker, G; Gutmann, H; Miller, DS; Toeroek, M | 1 |
| Asawakarn, T; Cladera, J; O'Shea, P | 1 |
| Eilers, M; Mondal, D; Roy, U | 1 |
| Chakravarty, G; Honer Zu Bentrup, K; Mondal, D; Roy, U | 1 |
| Annaert, P; Augustijns, P; Camus, S; Ye, ZW | 1 |
| Davis, BM; Davis, S; O'Shea, P; Petrov, PG; Richens, JL; Vere, KA; Winlove, CP | 1 |
6 other study(ies) available for erythrosine and saquinavir
| Article | Year |
|---|---|
Interactions of HIV protease inhibitors with ATP-dependent drug export proteins.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cyclosporine; Fluoresceins; HIV Protease Inhibitors; Killifishes; Methotrexate; Mitochondrial Proteins; Ribosomal Proteins; Ritonavir; Saccharomyces cerevisiae Proteins; Saquinavir | 1999 |
Effects of the membrane dipole potential on the interaction of saquinavir with phospholipid membranes and plasma membrane receptors of Caco-2 cells.
Topics: beta-Cyclodextrins; Binding, Competitive; Caco-2 Cells; Calcium; Cell Line; Cell Membrane; Colchicine; Cyclodextrins; Dose-Response Relationship, Drug; Fluoresceins; HIV Protease Inhibitors; Humans; Ions; Ketocholesterols; Membrane Microdomains; Membrane Potentials; Phloretin; Phosphatidylethanolamines; Phospholipids; Polylysine; Protein Binding; Pyridinium Compounds; Saquinavir; Signal Transduction; Spectrometry, Fluorescence; Time Factors | 2001 |
MRP (ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and zidovudine, from human endothelial cells.
Topics: Anti-HIV Agents; Aorta; Brain; Cells, Cultured; Endothelial Cells; Fluoresceins; Gene Expression Regulation; Humans; Multidrug Resistance-Associated Proteins; Saquinavir; Zidovudine | 2008 |
Montelukast is a potent and durable inhibitor of multidrug resistance protein 2-mediated efflux of taxol and saquinavir.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Antineoplastic Agents, Phytogenic; Biological Transport; Cell Line; Chemotherapy, Adjuvant; Cyclopropanes; Dogs; Drug Resistance, Neoplasm; Drug Resistance, Viral; Fluoresceins; HIV Infections; HIV Protease Inhibitors; Indoles; Leukotriene Antagonists; Multidrug Resistance-Associated Proteins; Neoplasms; Paclitaxel; Phenylcarbamates; Propionates; Quinolines; Saquinavir; Sulfides; Sulfonamides; Time Factors; Tosyl Compounds | 2009 |
Interaction of eight HIV protease inhibitors with the canalicular efflux transporter ABCC2 (MRP2) in sandwich-cultured rat and human hepatocytes.
Topics: Animals; Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carbamates; Cells, Cultured; Fluoresceins; Furans; Hepatocytes; HIV Protease Inhibitors; Humans; Indinavir; Liver; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Nelfinavir; Rats; Rats, Wistar; Ritonavir; Saquinavir; Sulfonamides | 2010 |
α-Tocopherols modify the membrane dipole potential leading to modulation of ligand binding by P-glycoprotein.
Topics: alpha-Tocopherol; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Membrane; Fluoresceins; Fluorescent Dyes; Humans; Jurkat Cells; Ketocholesterols; Ligands; Membrane Potentials; Models, Molecular; Molecular Conformation; Phosphatidylethanolamines; Protein Binding; Pyridinium Compounds; Saquinavir; Unilamellar Liposomes | 2015 |